156
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies

, &
Pages 43-67 | Published online: 11 Jul 2009

  • Aman, M.G., Kern, R.A., Osborne, P., Tumuluru, R., Rojahn, J. and del Medico, V. (1997). Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects. American Journal of Mental Retardation, 101, 521-534.
  • Anderson, G.M., Braun, G., Braun, U., Nichols, D.E. and Shulgin, A.T. (1978). Absolute configuration and psychotomimetic activity. Nida Research Monograph, 33(22), 8-15.
  • Aulakh, C.S., Hill, J.L., Wozniak, K.M. and Murphy, D.L. (1988). Fenfluramineinduced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline. Psychopharmacology, 95, 313-317.
  • Bakshi, V.P. and Geyer, M.A. (1998). Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. Journal of Neuroscience, 18(20), 8394-8401.
  • Bakshi, V.P. and Geyer, M.A. (1999). Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience, 92, 113-121.
  • Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I. and BaIi, L. (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology, 15, 339-343.
  • Braff, D.L. and Geyer, M.A. (1990). Sensorimotor gating and schizophrenia: Human and animal model studies. Archives General Psychiatry, 47, 181-188.
  • Braff, D.L., Grillon, C. and Geyer, M.A. (1992). Gating and habituation of the startle reflex in schizophrenic patients. Archives General Psychiatry, 49, 206-215.
  • Cadenhead, K.S., Geyer, M.A. and Braff, D.L. (1993). Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. American Journal of Psychiatry, 150, 1862-1867.
  • Caine, S.B., Geyer, M.A. and Swerdlow, N.R. (1991). Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat. Psyche-pharmacology, 105, 347-354.
  • Caine, S.B., Geyer, M.A. and Swerdlow, N.R. (1992). Hippocampal modulation of acoustic startle and prepulse inhibition in the rat. Pharmacology Biochemistry and Behavior, 43, 1201-1208.
  • Callaway, C.W., Wing, L.L. and Geyer, M.A. (1990). Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. Journal of Pharmacology and Experimental Therapeutics, 254(2), 456-464.
  • Callaway, C.W., Johnson, M.P., Gold, L.H., Nichols, D.E. and Geyer, M.A. (1991a). Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology, 104(3), 293-301.
  • Callaway, C.W., Nichols, D.E., Paulus, M.P. and Geyer, M.A. (1991b). Serotonin release is responsible for the locomotor hyperactivity in rats induced by derivatives of amphetamine related to MDMA. In: Fozard, J.R. and Saxena, P.R. (Eds.), Serotonin: Molecular Biology, Receptors, and Functional Effects, pp. 491-505. Basel, Birkhauser.
  • Callaway, C.W. (1992). Behavioral effects of serotonin release by substituted derivatives of amphetamine. University of California, San Diego.
  • Callaway, C.W. and Geyer, M.A. (1992b). Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine IB agonist. Journal of Pharmacology and Experimental Therapeutics, 263(1), 318-326.
  • Callaway, C.W., Rempel, N., Peng, R.Y. and Geyer, M.A. (1992). Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology, 7(2), 113-127.
  • Carasso, B.S., Bakshi, V.P. and Geyer, M.A. (1998). Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology, 37(3), 401-404.
  • Christophersen, A.S. (2000). Amphetamine designer drugs - an overview and epidemiology. Toxicology Letters, 112-113, 127-131.
  • Davis, M., Gendelman, D.S., Tischler, M.D. and Gendelman, P.M. (1982). A primary acoustic startle circuit: Lesion and stimulation studies. Journal of Neuroscience, 2, 791-805.
  • Davis, M. (1984). The mammalian startle response. In: Eaton, R.C. (Ed.), Neural Mechanisms of Startle Behavior, pp. 287-342. New York, Plenum Press.
  • Drug Enforcement Administration (1993). Federal Register, 58(47), 13533.
  • Drug Enforcement Administration (1996). Controlled Substances Act, 13(812).
  • Dulawa, S.C. and Geyer, M.A. (1996). Psychopharmacology of prepulse inhibition in mice. Chinese Journal of Physiology, 39(3), 139-146.
  • Dulawa, S.C., Hen, R., Scearce-Levie, K. and Geyer, M.A. (1998). 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice. Annals of the New York Academy of Sciences, 861(2), 79-84.
  • Gaggi, R., Dallolio, R. and Roncada, P. (1997). Effects of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats. General Pharmacology, 28(4), 583-587.
  • Garattini, S., Buczko, W., Jori, A. and Samanin, R. (1975). The mechanism of action of fenfluramine. Postgraduate Medical Journal, 51 (Suppl 1), 27-35.
  • Gazzara, R.A., Takeda, H., Cho, A.K. and Howard, S.G. (1989). Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. European Journal of Pharmacology, 168(2), 209-217.
  • Geyer, M.A. and Braff, D.L. (1982). Habituation of the blink reflex in normals and schizophrenic patients. Psychophysiology, 19, 1-6.
  • Geyer, M.A., Russo, P.V. and Masten, V.L. (1986). Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacology, Biochemistry and Behavior, 25(1), 277-288.
  • Geyer, M.A., Russo, P.V., Segal, D.S. and Kuczenski, R. (1987). Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacology, Biochemistry and Behaviour, 28(3), 393-399.
  • Geyer, M.A. and Tapson, G.S. (1988). Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology, 1(2), 135-147.
  • Geyer, M.A. and Callaway, C.W. (1994). Behavioral pharmacology of ring-substituted amphetamine analogs. In: Cho, A.K. and Segal, D.S. (Eds.), Amphetamine and its Analogs: Neuropsychopharmacology Toxicology and Abuse, pp. 177-208. Academic Press, New York.
  • Geyer, M.A. (1995). Serotonergic functions in arousal and motor activity. Behavioural Brain Research, 73, 31-35.
  • Glennon, R.A. (1993). MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethy1 homolog of DOM. Pharmacology, Biochemistry and Behavior, 46, 459-462.
  • Gold, L.H., Koob, G.F. and Geyer, M.A. (1988). Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. Journal of Pharmacology and Experimental Therapeutics, 247(2), 547-555.
  • Gotestam, K.G. and Gunne, L.M. (1972). Subjective effects of two anorexigenic drugs fenfluramine and AN448 in amphetamine-dependent subjects. British Journal of Addiction, 67, 39-44.
  • Graham, F. (1975). The more or less startling effects of weak prestimulation. Psychophysiology, 12, 238-248.
  • Greer, G. and Strassman, R.J. (1985). Information on "Ecstasy" [letter]. American Journal of Psychiatry, 142(11), 1391.
  • Greer, G. and Tolbert, R. (1986). Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs, 18, 319-327.
  • Griffith, J.D., Nutt, J.G. and Jasinki, D.R. (1975). A comparison of fenfluramine and amphetamine in man. Clinical Pharmacology and Therapeutics, 18, 563-570.
  • Harvard Heart Letter (2000). Was the danger of diet pills overstated? 10(6), 4-5.
  • Hatzidimitriou, G., McCann, U.D. and Ricaurte, G.A. (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery. Journal of Neuroscience, 19, 5096-5107.
  • Hekmatpanah, C.R. and Peroutka, S.J. (1990). 5-hydroxytryptamme uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. European Journal of Pharmacology, 177, 95-98.
  • Hoffman, H.S. and Searle, J.L. (1968). Acoustic and temporal factors in the evocation of startle. Journal of the Acoustic Society of America, 43, 269-282.
  • Ison, J.R. and Hoffman, H.S. (1983). Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon. Psychological Bulletin, 94, 3-17.
  • Jacobs, B.L. and Fornal, C.A. (1997). Serotonin and motor activity. Current Opinion in Newobiology, 7(6), 820-825.
  • Kannengiesser, M.H., Hunt, P.P. and Raynaud, J.P. (1976). Comparative action of fenfluramine on the uptake and release of serotonin and dopamine. European Journal of Pharmacology, 35, 35-43.
  • Kehne, J.H., McCloskey, T.C., Taylor, V.L., Black, C.K., Fadayel, G.M. and Schmidt, C.J. (1992). Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloramphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. Journal of Pharmacology and Experimental Therapeutics, 260, 78-79.
  • Kehne, J.H., Padich, R.A., McCloskey, T.C., Taylor, V.L. and Schmidt, C.J. (1996). 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology, 124, 95-106.
  • Kleven, M.S., Schuster, C.R. and Seiden, L.S. (1988). Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine, Journal of Pharmacology and Experimental Therapeutics, 246,822-828.
  • Komiskey, H.L. and Rudy, T.A. (1977). Serotonergic influences on brain stem thermoregulatory mechanisms in the cat. Brain Research, 134, 297-315.
  • Krebs, K.M. and Geyer, M.A. (1993). Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats. Psychopharmacology, 113, 284-287.
  • Kroeze, W.K. and Roth, B.L. (1998). The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis. Biological Psychiatry, 44, 1128-1142.
  • Lawn (1985). Schedules of controlled substances: temporary placement of 3,4-methylenedioxymethamphetamine (MDMA) into Schedule I. Federal Register, 50, 23118-23120.
  • Liechti, M.E., Baumann, C., Gamma, A. and Vollenweider, F.X. (2000). Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology, 22, 513-521.
  • Lindquist, M.P. and Gotestam, K.G. (1977). Open field behavior after intravenous amphetamine analogues in rats. Psychopharmacology, 55, 129-133.
  • Lipska, B.K., Jaskiw, G.E., Arya, A. and Weinberger, D.R. (1992). Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacology Biochemistry and Behavior, 43, 1247-1252.
  • Lucki, L, Kreider, M.S. and Simansky, K.J. (1988). Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychopharmacology (Berlin), 96, 289-295.
  • Lucki, I. (1998). The spectrum of behaviors influenced by serotonin. Biological Psychiatry, 44, 151-162.
  • Mansbach, R.S., Geyer, M.A. and Braff, D.L. (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology, 94(4), 507-514.
  • Mansbach, R.S., Braff, D.L. and Geyer, M.A. (1989). Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamme (MDEA) in the rat. European Journal of Pharmacology, 167(1), 49-55.
  • Martinez, D.L. and Geyer, M.A. (1997a). A 5-HT IB antagonist blocks effects of RU 24969 on locomotor, but not investigatory, activity in rats. Society for Neuroscience Abstracts,23,5l9.
  • Martinez, D.L. and Geyer, M.A. (1997b). Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine. Neuropsychopharmacology, 16(3), 246-255.
  • Martinez, D.L. and Geyer, M.A. (1998). Localization of RU 24969-induced changes in locomotor activity and investigatory holepokes. Society for Neuroscience Abstracts, 24, 1922.
  • Martinez, D.L. and Geyer, M.A. (1999). Site-specific effects and dissociation of RU 24969-induced changes in locomotor activity and investigatory holepokes. Society for Neuroscience Abstracts, 25, 1124.
  • McCann, U.D. and Ricaurte, G.A. (1993). Reinforcing subjective effects of (+/-)3,4methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence. Journal of Clinical Psychopharmacology, 13(3), 214-217.
  • McCann, U.D., Seiden, L.S., Rubin, L.J. and Ricaurte, G.A. (1997). Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. Journal of the American Medical Association, 278, 666-672.
  • McCann, U.D., Eligulashvili, V. and Ricaurte, G.A. (1998). Adverse neuropsychiatrie events associated with dexfenfluramine and fenfluramine. Progress in Neuropsychopharmacology and Biological Psychiatry, 22, 1087-1102.
  • McKenna, D.J., Guan, X.M. and Shulgin, A.T. (1991). 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacology Biochemistry and Behavior, 38, 505-512.
  • Muldoon, M.F., Manuck, S.B., Jansma, C.L., Moore, A.L., Perel, J. and Mann, J.J. (1996). D,L-fenfluramine challenge test: experience in nonpatient sample. Biological Psychiatry, 39, 761-768.
  • Naranjo, C., Shulgin, A.T. and Sargent, T. (1980). Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct of psychotherapy. Medicina et Phannacologia Experimentalis, 17, 359-364.
  • Nichols, D.E., Hoffman, A.J., Oberlender, R.A., Jacob, P. and Shulgin, A.T. (1986). Derivatives of 1-(1,3-benzodioxol-5-y1)-2butanamine: Representatives of a novel therapeutic class. Journal of Medicinal Chemistry, 29, 2009-2015.
  • Nicholson, A.N., Belyavin, A.J. and Pascoe, P.A. (1989). Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission, Neuropsychopharmacology. 2, 131-143.
  • O'Neill, M.F. and Parameswaran, T. (1997). RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors. Psychopharmacology, 132(3), 255-260.
  • Padich, R.A., McCloskey, T.C. and Kehne, J.H. (1996). 5-HT modulation of auditory and visual sensorimotor gating: H. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology, 124, 107-116.
  • Paulus, M.P. and Geyer, M.A. (1992). The effects of MDMA and other methylenedioxysubstituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology, 7(1), 15-31.
  • Preval, H. and Pakyurek, A.M. (1997). Psychotic episode associated with dexfenfluramine [letter]. American Journal of Psychiatry, 154(11), 1624-1625.
  • Raison, C.L. and Klein, H.M. (1997). Psychotic mania associated with fenfluramine and phentermine use. American Journal of Psychiatry, 154(5), 711.
  • Rempel, N.L., Callaway, C.W. and Geyer, M.A. (1993). Serotonin 1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology, 8(3), 201-211.
  • Ricaurte, G.A., Bryan, G., Strauss, L., Seiden, L. and Schuster, C. (1985). Hallucinogenic amphetamine selectively destroys serotonin nerve terminals. Science, 229, 986-988.
  • Ricaurte, G.A., McCann, U.D., Szabo, Z. and Scheffel, U. (2000). Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Toxicology Letters, 112-113, 143-146.
  • Rueter, L.E., Fornal, C.A. and Jacobs, B.L. (1997). A critical review of 5-HT brain microdialysis and behavior. Reviews of Neuroscience, 8, 117-137.
  • Salles, M.S. and Salles, K.S. (1980). Behavioral effect of selective and non-selective lesions of median raphe nucleus in the rat. Japanese Journal of Physiology, 30, 105-114.
  • Samanin, R., Ghezzi, D., Valzelli, L. and Garattini, S. (1972). The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine. European Journal of Pharmacology, 19, 318-322.
  • Schecter, M.D. (1986). Discriminative profile of MDMA. Pharmacology Biochemistry and Behavior, 24, 1533-1537.
  • Schmidt, C.J. and Kehne, J.H. (1990). Neurotoxicity of MDMA: neurochemical effects. Annals of the New York Academy of Sciences, 600(1-2), 665-680; discussion 680-681.
  • Schmidt, C.J. and Taylor, V.L. (1990). Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. European Journal of Pharmacology, 181(1-2), 133-136.
  • Schwartz, D., Hernandez, L. and Hoebel, E.G. (1989). Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Research, 482, 261-270.
  • Shulgin, A.T. (1986). The background and chemistry of MDMA. Journal of Psychoactive Drugs, 18(4), 291-304.
  • Sipes, T.E. and Geyer, M.A. (1995). DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors. Behavioural Pharmacology, 6, 839-842.
  • Sipes, T.E. and Geyer, M.A. (1997). DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Research, 761, 97-104.
  • Swerdlow, N.R., Braff, D.L. and Geyer, M.A. (1990). GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Research, 532, 146-150.
  • Swerdlow, N.R., Caine, S.B., Braff, D.L. and Geyer, M.A. (1992). Neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications. Journal of Psychopharmacology, 6, 176-190.
  • Swerdlow, N.R., Benbow, C.H., Zisook, S., Geyer, M.A. and Braff, D.L. (1993). A preliminary assessment of sensorimotor gating in patients with Obsessive Compulsive Disorder. Biological Psychiatry, 33, 298-301.
  • Swerdlow, N.R., Paulsen, J., Braff, D.L., Butters, N., Geyer, M.A. and Swenson, M.R. (1995). Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. Journal of Neurology. Neurosurgery and Psychiatry, 58(2), 192-200.
  • The Novartis Foundation (1998). Ecstasy (MDMA): a human neurotoxin? Conference Proceedings, London, England, 12/4/1998.
  • Vollenweider, F.X., Remensberger, S., Hell, D. and Geyer, M.A. (1999). Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology, 143, 365-372.
  • Yaksh, T.L. and Wilson, P.R. (1979). Spinal serotonin terminal system mediates antinociception. Journal of Pharmacology and Experimental Therapeutics, 208, 446-453.
  • Ziance, R.J., Sipes, I.G., Kinnard, W.J. and Buckley, J.P. (1972). Central nervous system effects of fenfluramine hydrochloride. Journal of Pharmacology and Experimental Therapeutics, 180, 110-117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.